Sources | Names Used |
---|---|
GDSC1000, FIMM | Cytarabine |
CTRPv2 | cytarabine hydrochloride |
PharmacoGx | Cytarabine |
Database | Identifier |
---|---|
Smiles: | C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O.Cl |
Inchikey: | KCURWTAZOZXKSJ-UHFFFAOYSA-N |
Pubchem: | 5351180 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NASP | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-14 |
mRNA | YIPF5 | CTRPv2 | pan-cancer | AAC | -0.24 | 5e-14 |
mRNA | PROSER1 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-14 |
mRNA | TAF5L | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-14 |
mRNA | ZNF184 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-14 |
mRNA | USP49 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-14 |
mRNA | URB2 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-14 |
mRNA | KLHL23 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-14 |
mRNA | HADH | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-13 |
mRNA | EZH2 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-13 |